# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-20-017370
Filing Date
2020-12-10
Accepted
2020-12-10 17:18:48
Documents
104
Period of Report
2020-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | cpix-20201210_d2.htm iXBRL | 8-K | 50046
2 | EX-23.1 | a12920208-kex231.htm | EX-23.1 | 3000
3 | EX-99.1 | cpix-20201210.htm iXBRL | EX-99.1 | 1896348
| Complete submission text file | 0001628280-20-017370.txt |  | 10214565

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20201210.xsd | EX-101.SCH | 78515
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20201210_cal.xml | EX-101.CAL | 144639
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20201210_def.xml | EX-101.DEF | 349834
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20201210_lab.xml | EX-101.LAB | 867420
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20201210_pre.xml | EX-101.PRE | 593005
9 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20201210_d2_htm.xml | XML | 1831811

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 201381468
SIC: 2834 Pharmaceutical Preparations